Introduction
Pharmacists have training and expertise in medication therapy and the patient care capabilities to assess and respond to the health care and drug-related needs of patients. Although pharmacists are often perceived as medication dispensers, their professional role goes well beyond this simplistic characterization. Pharmacists are important members of the health care team who have the skill and knowledge to initiate, monitor and adjust drug therapy, 1 and they are well recognized by the general public as being knowledgeable about medications. 2 Although medical and dental care providers dominate prescribing activity, other health care professionals such as optometrists, podiatrists, midwives and CHOWDHURY FARHANA FARUQUEE CLInICAL RevIeW nurse practitioners have been granted prescribing rights. 3 Similarly, pharmacists' expanded professional role includes prescribing. Pharmacist prescribing is different from prescribing by other health care professionals. Depending on the jurisdiction, pharmacists may alter or adapt a prescription, renew a prescription for continuity, provide an emergency supply or initiate a new medication therapy (i.e., prescription and nonprescription therapies). 4 The jurisdictive power of prescribing by pharmacists varies between countries. Internationally, there are different models of pharmacist prescribing. 1, 5 In the United Kingdom, supplementary prescribing (i.e., prescribing authorities through different protocols or formularies) by pharmacists was approved in 2003. In 2006, pharmacists obtained independent prescribing rights (i.e., prescribing personnel are solely responsible for patient assessment, initiation of therapy and clinical management). 1, 6, 7 In the United States, there are 2 models of pharmacist prescribing. Over 41 US states allow dependent prescribing as a part of collaborative drug therapy management and 5 states allow collaborative prescribing of controlled substances. [8] [9] [10] The independent prescribing model was first introduced in a US Department of Veterans Affairs outpatient clinic in Florida. 9 In contrast with the United Kingdom and the United States, prescribing in Canada varies by jurisdiction. In the last 7 years, provinces in Canada have introduced a number of differing policies regarding the extended scope of pharmacy practice, especially with regard to prescribing activities. 5 Pharmacists can independently prescribe in 7 of 10 provinces. In Canada, independent prescribing includes extending existing prescriptions (10 provinces), adapting existing prescriptions (i.e., change of drug dosage and formulation in 9 provinces and therapeutic substitution in 7 provinces) and initiating new prescriptions (7 provinces). 11 In some provinces (Saskatchewan, Nova Scotia and Prince Edward Island), initiating new prescriptions refers to pharmacist prescribing only as part of assessment and prescribing for minor ailments (otherwise referred to as ambulatory conditions). 11 In Alberta, pharmacists with additional prescribing authority can prescribe prescriptiononly drugs, excluding narcotics and controlled substances based on their initial assessment or in collaboration with either another authorized prescriber or regulated health professional with nonprescriptive authority. 4 There is variability in provincial-and employer-sponsored reimbursement for patients for prescriptions written by a pharmacists. 10 The objective of prescribing by pharmacists is to make use of pharmacists' expertise and knowledge to improve the health of Canadians. Legislation and practice models are changing depending on the effects on patient care and patient outcomes of prescribing by pharmacists. 5 There has been noteworthy discussion in the literature about the benefits and problems of the expanded scope of pharmacists' practice in Canada. 5 For 7 years, pharmacists have performed many types of prescribing within the country. Therefore, we aimed to review the empirical literature on pharmacist prescribing in Canada.
The objective of this scoping review was to characterize the literature on prescribing by pharmacists in Canada according to methodological trends, research areas and key findings.
Methods

Scoping review
We conducted a scoping review of the research on the prescriptive authority of Canadian pharmacists. The purpose of a scoping review is to provide an overview of the volume, array and nature of research activity by mapping the available literature for a particular field of study. 12 Scoping reviews identify the gaps in existing literature but do not assess research quality. 12 
KNOWLEDGE INTO PRACTICE
• Early research on pharmacist prescribing showed improved medication use, economic benefit and patient outcomes in heart disease, diabetes and minor ailments (i.e., ambulatory conditions). • The pharmacy profession needs to effectively communicate the benefits of pharmacist prescribing in both individual interactions and promotional communication while remaining sensitive to the differing views of stakeholders. • Researchers can focus on developing strategies to improve medication adherence, cost savings and interprofessional collaboration through appropriate application of pharmacist prescribing. • Researchers and pharmacists could work together to evaluate prescribing models between provinces to allow for identification of best policies and practices.
CLINICAL REVIEW
Search strategy
The following 3 electronic databases were searched without any limitations on the date of publication: Ovid MEDLINE, Ovid EMBASE and International Pharmaceutical Abstracts. Key search terms included "pharmacist prescribing, " "prescribing by protocol or protocol-based prescribing, " "collaborative prescribing, " "independent or supplementary prescribing, " "adaptation of prescription" and "minor ailment prescribing. " These were combined with search terms related to Canadian or different provinces and territories of Canada. We used different terms because the context of pharmacist prescribing varies across Canada. For example, prescribing is called "expanded role" or "additional prescribing authority" in Alberta, "adaptation service" in British Columbia and "minor ailment prescribing" in Saskatchewan, Manitoba and Nova Scotia.
MISE EN PRATIQUE DES CONNAISSANCES
• Les premières études sur la prescription par les pharmaciens ont montré une amélioration des résultats des patients pour les maladies cardiaques, le diabète et les troubles mineurs (états ambulatoires), l'utilisation des médicaments et les avantages économiques. • La profession pharmaceutique doit communiquer efficacement les avantages de la prescription par les pharmaciens dans le cadre des interactions en personne et de communications promotionnelles, tout en continuant de respecter les opinions divergentes des intervenants. • Les chercheurs peuvent se concentrer sur l'élaboration de stratégies visant à améliorer l'observance thérapeutique, les économies de coûts et la collaboration interprofessionnelle grâce à la bonne application de la prescription par les pharmaciens. • Les chercheurs et les pharmaciens pourraient unir leurs efforts afin d'évaluer des modèles de prescription entre les provinces afin de déterminer les politiques et pratiques les plus efficaces. 
CLInICAL RevIeW
A detailed search strategy is presented in Appendix 1 (available online at cph.sagepub. com/supplemental). All search results were then exported to RefWorks reference manager software and duplicates were removed. The search results are shown in Figure 1 .
Study selection
Studies were eligible for inclusion if they were related to prescribing activities of pharmacists in Canada and were published in English as peerreviewed research articles or abstracts. Both authors screened each article in 2 stages independently. In the first stage, we reviewed titles and abstracts for potential relevance. In the second stage, we obtained full-text articles for further evaluation and examined them to determine eligibility. We resolved any discrepancies regarding inclusion by discussion.
Data synthesis
We used a standardized form to extract data from the selected studies and verified the data for accuracy and inclusiveness. The following study characteristics were recorded: lead author, year of publication, location, participants, methods, analysis, results or key findings and research design. We categorized the literature according to methodological trends, research areas and key findings. 13 The guiding questions were as follows: "What data analysis techniques are most commonly used in research?" and "What is the range and frequency of topics being explored in research?" Initially, we organized the research by research methods, using inferential statistics, descriptive statistics and qualitative or combined data analysis methodologies. We were open to adding categories as required. We extracted and categorized all research questions to understand the breadth of ideas and themes. We then compared the study topics to find similarities and clustered them into broader categories. We identified the gaps after analyzing the data and themes extracted from the existing literature.
Results
We identified 167 articles, excluding 127 articles after initial screening and 2 articles after full-text assessment for eligibility, resulting in 26 articles and 12 abstracts that met the inclusion criteria ( Figure 1 ). These publications represent 35 data sets. Findings are summarized in tables organized by research areas (Tables 1-5).
We found 20 quantitative studies, 11 qualitative studies, 3 mixed-method studies, 1 case study, 1 observation and 2 document analyses. Quantitative articles used surveys (8 studies), 2,14-20 experiments (3 studies), [21] [22] [23] randomized controlled trials (5 studies) [24] [25] [26] [27] [28] and others (4 studies). [29] [30] [31] [32] Qualitative studies explored perceptions of pharmacists 33 or pharmacy students 34 (2 studies), stakeholders (3 studies), [35] [36] [37] media (1 study) 38 and different factors influencing the practice change (5 studies). [39] [40] [41] [42] [43] Two methodology articles described the mixed method (semistructured interview and survey) to explore pharmacists' perception about prescribing in Alberta, British Columbia and Ontario. 44, 45 Another mixed-method study used an online survey with both open-ended and 5-point scale questions to explore the public attitude toward the expanded role of pharmacists in Nova Scotia. 46 Two rich descriptions of regulatory changes summarized independent prescribing rights across Canada. 10, 47 Finally, there was a case study 48 and a description of higher education training of independent pharmacists. 49 Two studies among 11 qualitative studies were conducted in collaboration with Australia 34 and Scotland. 49 By analyzing the topics for similarities and grouping them into broader categories, we found 5 research areas: outcomes (13 studies), perceptions of prescribing (10 studies), practice changes (11 studies), regulatory changes (2 studies) and training (2 studies). Below we outline key findings by research area.
Thirteen studies measured the outcome or impact of pharmacist prescribing, including clinical, medication use and humanistic and economic outcomes (Table 1) . 18, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] 48 Three articles evaluating the outcomes of pharmacist prescribing on the use of antihypertensives, 24 cardiovascular risk reduction 28 and health care use 23 were on study design and did not report any results. All remaining studies reported benefits of pharmacist prescribing. Seven studies showed benefit in clinical patient outcomes. These studies found improved risk factor control in patients with prior stroke, 25 reduced systolic blood pressure 26, 31 and low-density lipoprotein cholesterol, 27 improved glycemic control in patients with poorly controlled type 2 diabetes 22 and improved quality of life in patients with uncontrolled type 2 diabetes in a cost-effective manner. 32 Better chronic disease management as well as significant symptomatic improvement was reported by 81% of patients when pharmacists prescribed agreed with increased patient convenience and benefit to the health care system as a result of pharmacist prescribing. On the other hand, physicians showed concern about patient safety and delegation of authority Qualitative (continued) CLInICAL RevIeW medications for minor ailments (i.e., ambulatory conditions) in Saskatchewan. 18 A case study showed that pharmacist prescribing in collaboration with other health care professionals facilitated the detection of an underlying disease. 48 Two studies showed that pharmacist prescribing improved medication use, with increased drugrelated problem identification 29 and increased use of emergency contraceptive pills. 30 Finally, one study showed benefit in humanistic and economic outcomes in terms of improved quality of life and cost-effectiveness when pharmacists initiated insulin therapy in patients with uncontrolled type 2 diabetes. All of the studies used quantitative methods, except the case study. 18, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] 48 Among 12 quantitative studies, 5 were randomized controlled trials. [24] [25] [26] [27] [28] Perception or insight about pharmacist prescribing was evident in 10 studies ( Table 2) . Researchers used different perspectives, such as the general public, students, government agencies, physicians and pharmacists themselves, to understand the insight. 2, [33] [34] [35] [36] [37] [38] [44] [45] [46] The general public in Saskatchewan and Nova Scotia agreed with pharmacist prescribing for managing minor ailments (i.e., ambulatory conditions), 2,46 emergencies 2 and prescription renewal 46 but showed less support in diagnosing new diseases and prescribing a treatment plan. 2 Pharmacy students and health care stakeholders perceived that independent prescribing was shaping the profession in the right direction, 34 increasing convenience for patients and benefiting health care delivery. 36, 37 On the other hand, physicians expressed concerns about patient safety and delegation of authority. 36 Pharmacy owners and managers reported a benefit to prescribing, in addition to multiple workplace barriers. 35 Similarly, newspaper analysis revealed contradictory views, a lack of clarity and a lack of consistency in pharmacist prescribing. 38 Pharmacists in British Columbia were in favour of potentially prescribing oral contraceptive pills but had concerns about liability. 45 Pharmacists in Alberta with experience in prescribing defined it in 1 of 3 ways: the physical task of writing a prescription, an integral part of patient care and a legislated definition of prescribing. 33 Results were not included in 1 article on study design. 44 Nine of 10 studies used qualitative methods that were either qualitative only [33] [34] [35] [36] [37] [38] or were combined with quantitative surveys. [44] [45] [46] Face-to-face, telephone and interview surveys were used in these 9 studies. A documented analysis was added to 1 group of interviews 37 and was the sole method in another group. 38 We found 11 studies on practice change that focused on 3 areas: the extent of pharmacist prescribing, factors that influence pharmacists' uptake of prescribing and the impact of prescribing on workload and collaboration (Table 3 ). [14] [15] [16] [17] 19, 20, [39] [40] [41] [42] [43] The level and extent of prescribing adoption in different settings was analyzed in 2 studies. These studies found greater adoption of advanced prescribing activity in patient-focused pharmacists than in product-focused pharmacists, 40 and there was a greater practice of adjusting ongoing medications than initiating a new prescription by pharmacists with additional prescribing authority. 19 Six studies summarized factors influencing pharmacist prescribing. Three of these studies reported the value of additional prescribing authority and increased efficiency as motivating factors and the increased risk, liability and lengthy application process as drawbacks. 14, 41, 42 Practice setting was found to be an impelling factor, because there was more patientfocused prescribing in primary care networks than in community settings. 39 Again, 2 pharmacist surveys showed personality traits as a driving factor of adoption of prescribing, and these studies reported that pharmacists with more extroversion and openness made greater progress on their applications for additional prescribing authority. 15, 16 Pharmacist prescribing also affected their workload and collaboration. 17, 20, 43 Increased service time and labour cost was found in British Columbia due to adaptation services provided by pharmacists. 17 In Saskatchewan, researchers will examine pharmacist workload after the introduction of prescribing. 20 Pharmacist prescribing also influenced collaboration and interprofessional communication. 43 In community settings, collaboration is encouraged by the process of sharing prescribing decisions with other prescribers, especially physicians. On collaborative teams, pharmacists are empowered with the ability to assess patients and implement care plans. 43 Mostly quantitative survey methods were used in this research area. [14] [15] [16] [17] 19, 20 One abstract was on study design and did not report any results. 20 In qualitative studies, researchers analyzed semistructured telephone interviews 39, 40 and written responses to open-ended questions on an e-mail survey. 41 Regulatory changes were the focus in 2 studies (Table 4 ). 10, 47 In the first study, researchers CLINICAL REVIEW summarized prescribing rights across Canada and identified significant diversity among provincial regulations. 10 In the second study, a policy analysis of legislation in Alberta showed that pharmacist prescribing resulted from a legislative opportunity that was supported by strong communication among stakeholders, research evidence and early identification and resolution of stakeholder barriers. 47 Two studies concentrated on evaluating training programs to improve knowledge of prescribing pharmacists (Table 5) . 21, 49 One study showed that training significantly increased pharmacists' knowledge on prescribing the emergency contraceptive pill. 21 A qualitative abstract described a collaborative project in which 5 pharmacists from Nova Scotia participated in a 1-week training program on independent pharmacist prescribing in Scotland. 49
Discussion
We analyzed the pharmacy practice literature on pharmacist prescribing in Canada from 3 perspectives: design trends, research areas and key findings. We found that most evaluations were quantitative, focused on patient outcomes and reported positive health care impacts of pharmacist prescribing. Qualitative research mostly explored perceptions regarding pharmacist prescribing and found contradictory views of different stakeholders and different aspects of practice change.
In terms of study design, we found predominately quantitative methods, including surveys, trials and experimental designs, and fewer qualitative or mixed-methods studies. By contrast, researchers in the United Kingdom used mostly qualitative methods to understand the prescribing activity by pharmacists. 50 Because prescribing by pharmacists is a new paradigm in Canada, the use of qualitative research methods may help to acquire in-depth understanding of how and why pharmacists are behaving in a particular way. 51 We found 3 mixed-methods studies, which may generate in-depth and multifaceted information to understand pharmacist prescribing.
In the spectrum of research areas, we found a major emphasis on outcome in the literature and equivalent importance was placed on perception and practice change. By contrast, most of the literature based on UK practice explored perceptions of different stakeholders, with limited focus on clinical and economical outcomes and practice change. 52 The unique prescribing models in Canada and the United Kingdom may account for this. In the United Kingdom, pharmacists first were authorized for dependent prescribing, and the more recent independent model requires training with a short period of supervision by a medication practitioner. By contrast, Canadian pharmacists were authorized to prescribe with the intent of physician collaboration but without requirements for specific agreement or supervised training, resulting in less focus on stakeholder perceptions. A substantial application of quantitative research methodology was found in this area to identify outcomes 17, 18, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] and practice change, [14] [15] [16] 19, 20 whereas most of the qualitative and mixed-methods approaches were used to explore perceptions or insights about pharmacist prescribing [34] [35] [36] [37] [38] 44, 45 and practice change. [39] [40] [41] [42] [43] The growing quantitative research may indicate the need for a meta-analysis that addresses the impact of pharmacist prescribing on patient health.
Research on stakeholder perceptions of pharmacist prescribing in Canada suggest the coexistence of multiple and contradictory views. 38 On one hand, government agencies and pharmacists exhibited immense support of prescribing to improve patient access to medications. 37 On the other hand, physicians expressed concerns regarding patient safety and pharmacists' lack of diagnostic skill. 36 Physicians in the United Kingdom believe that supplementary prescribing (i.e., physicians have direct oversight) by pharmacists improved overall patient care, but concerns were expressed regarding independent prescribing and pharmacists' role in diagnosis. 36, 53 Negative outcomes of pharmacist prescribing have not been documented in the literature. In fact, the burden of medication misuse has resulted in calls to review the competence of all prescribers. 54, 55 By contrast, Canadian research shows that pharmacist prescribing improved patient outcomes. 18, 22, 29, 48 In Canada, the general public tentatively supported an expanded role for pharmacists in tasks familiar to patients, such as continuing ongoing medication therapy. 2 Conversely, patients in the United Kingdom perceived pharmacists as an alternative to doctor prescribing in primary care, and there is general acceptance of pharmacist prescribing. 52, 56 In Australia, patients supported pharmacists' prescribing roles but preferred that physicians play the main role in diagnosis. 57 However, the literature suggests that the general public and physicians have a low level of CLInICAL RevIeW understanding and speculative beliefs about an expanded role for pharmacists, and this may be due to a lack of clear communication. 2, 36 Accordingly, there is further opportunity to evaluate the experience of patients and other health care professionals with different types of pharmacist prescribing. Pharmacist prescribing may impact interdisciplinary collaboration, especially with physicians, and the extent of collaboration may depend on the complexity of the situation. Physicians may warrant collaboration when the pharmacist is prescribing in a multifaceted situation, whereas pharmacists will be confident enough to prescribe independently in less complex situations. Future research is needed to explore the impact of pharmacist prescribing on interdisciplinary collaboration. With increased experience in prescribing, researchers may identify how pharmacist prescribing, especially by renewal or in emergency situations, changes patient behaviours around obtaining and taking medications as well as adhering to drug therapy.
We identified several additional gaps in the literature. Geographically, prescribing research has focused on individual provinces and not the country as a whole. Prescribing was implemented at different times and in different ways in Canada, making national projects challenging. However, comparisons between provinces may identify best practices for pharmacist prescribing. Researchers could identify the impact of different prescribing models on health care costs, physicians' services and medication budgets. Empirical data could establish whether pharmacist prescribing does indeed increase patient access to medications and reduce physicians' workload as promised. Investment in research is required to address these questions.
In Canada, pharmacists with more patientcentred practice were more likely to prescribe, because they saw increased efficiency and value in the practice. Overall, many pharmacists reported training needs and physicians' response as barriers to their practice change. 14, 27, 41 This is similar to the findings of UK-based research. 58, 59 There was 1 study regarding the impact of training on the knowledge to prescribe, but it only concerned the emergency contraceptive pill. 21 However, it is necessary to find ways of addressing training requirements and educating pharmacists as well as physicians and other health care professionals regarding the scope of pharmacy practice.
Our conclusions have a few limitations. We narrowed our search to research articles and did not include the grey literature, theses or dissertations. We did not assess the quality of the research, as per scoping review methodology.
Conclusion
A developing body of research used mostly quantitative, qualitative and a few mixed methods to understand the effect and adoption of prescribing by pharmacists, related regulatory changes and insights about this new paradigm of health care practice in Canada. Pharmacist prescribing resulted in improvement in some chronic disease management (type 2 diabetes mellitus, hypertension, etc.) and use of emergency contraceptive pills. Stakeholders had diverse and at times contradictory understanding of pharmacist prescribing. Gaps in the literature include the impact of pharmacist prescribing on patient behaviours, medication adherence, cost savings and health systems. Future research directions may explore pharmacist prescribing in the context of an interprofessional health care system and may identify strategies to improve the collaborative relationship between pharmacists and physicians and other health care professionals. ■ From the Faculty of Pharmacy and Pharmaceutical Sciences, Edmonton Clinic Health Academy, University of Alberta, Edmonton, Alberta. Contact lguirgui@ualberta.ca.
